Research ExplorerPublicationsKonsummuster und Konsummotivation des Suchtmittelgebrauchs b...

Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten

Standard

Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten. / Lambert, M; Haasen, C; Mass, R; Krausz, M.

In: PSYCHIAT PRAX, Vol. 24, No. 4, 07.1997, p. 185-9.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Lambert, M, Haasen, C, Mass, R & Krausz, M 1997, 'Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten', PSYCHIAT PRAX, vol. 24, no. 4, pp. 185-9.

APA

Lambert, M., Haasen, C., Mass, R., & Krausz, M. (1997). Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten. PSYCHIAT PRAX, 24(4), 185-9.

Vancouver

Lambert M, Haasen C, Mass R, Krausz M. Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten. PSYCHIAT PRAX. 1997 Jul;24(4):185-9.

Bibtex

@article{9fc1da31cbd14867884e026d6bfd06d2,
title = "Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten",
abstract = "In particular studies conducted in the U.S. display a tendency for schizophrenics to combine hallucinogens and amphetamines, whereas other studies report on a combination of psychotropic substances with a similar range of action. Influencing negative symptoms is reported to be the motivation for consumption. A total of 222 patients with a schizophrenic disorder (F2) and addiction (F1) were examined. The main substance was alcohol (F10.1 or F10.2; 52.2%), followed by cannabis (F12; 25%), opiates (F11; 4.1%), sedatives or hypnotics (F13; 2.7%) and cocaine (F16; 0.5%). A multiple drug use (F19) is reported by 14% of them. The most frequent combination was alcohol and cannabis, whereas hallucinogens and amphetamines were only rarely combined. Actual multiple consumption was reported by 55% of the patients, while lifetime multiple consumption applied to 72%. The motivation seems to be an unspecified sedation of unpleasant affective symptoms of schizophrenia. The most frequently seen combinations do not correlate with the reports published in the literature. The great variations in motivation seem to mainly reflect the importance of the availability of the substance.",
keywords = "Adult, Alcoholism, Combined Modality Therapy, Comorbidity, Cross-Sectional Studies, Female, Germany, Humans, Incidence, Male, Medical History Taking, Middle Aged, Motivation, Patient Care Team, Psychiatric Status Rating Scales, Psychotropic Drugs, Schizophrenia, Schizophrenic Psychology, Self Medication, Street Drugs, Substance-Related Disorders",
author = "M Lambert and C Haasen and R Mass and M Krausz",
year = "1997",
month = jul,
language = "Deutsch",
volume = "24",
pages = "185--9",
journal = "PSYCHIAT PRAX",
issn = "0303-4259",
publisher = "Georg Thieme Verlag KG",
number = "4",

}

RIS

TY - JOUR

T1 - Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten

AU - Lambert, M

AU - Haasen, C

AU - Mass, R

AU - Krausz, M

PY - 1997/7

Y1 - 1997/7

N2 - In particular studies conducted in the U.S. display a tendency for schizophrenics to combine hallucinogens and amphetamines, whereas other studies report on a combination of psychotropic substances with a similar range of action. Influencing negative symptoms is reported to be the motivation for consumption. A total of 222 patients with a schizophrenic disorder (F2) and addiction (F1) were examined. The main substance was alcohol (F10.1 or F10.2; 52.2%), followed by cannabis (F12; 25%), opiates (F11; 4.1%), sedatives or hypnotics (F13; 2.7%) and cocaine (F16; 0.5%). A multiple drug use (F19) is reported by 14% of them. The most frequent combination was alcohol and cannabis, whereas hallucinogens and amphetamines were only rarely combined. Actual multiple consumption was reported by 55% of the patients, while lifetime multiple consumption applied to 72%. The motivation seems to be an unspecified sedation of unpleasant affective symptoms of schizophrenia. The most frequently seen combinations do not correlate with the reports published in the literature. The great variations in motivation seem to mainly reflect the importance of the availability of the substance.

AB - In particular studies conducted in the U.S. display a tendency for schizophrenics to combine hallucinogens and amphetamines, whereas other studies report on a combination of psychotropic substances with a similar range of action. Influencing negative symptoms is reported to be the motivation for consumption. A total of 222 patients with a schizophrenic disorder (F2) and addiction (F1) were examined. The main substance was alcohol (F10.1 or F10.2; 52.2%), followed by cannabis (F12; 25%), opiates (F11; 4.1%), sedatives or hypnotics (F13; 2.7%) and cocaine (F16; 0.5%). A multiple drug use (F19) is reported by 14% of them. The most frequent combination was alcohol and cannabis, whereas hallucinogens and amphetamines were only rarely combined. Actual multiple consumption was reported by 55% of the patients, while lifetime multiple consumption applied to 72%. The motivation seems to be an unspecified sedation of unpleasant affective symptoms of schizophrenia. The most frequently seen combinations do not correlate with the reports published in the literature. The great variations in motivation seem to mainly reflect the importance of the availability of the substance.

KW - Adult

KW - Alcoholism

KW - Combined Modality Therapy

KW - Comorbidity

KW - Cross-Sectional Studies

KW - Female

KW - Germany

KW - Humans

KW - Incidence

KW - Male

KW - Medical History Taking

KW - Middle Aged

KW - Motivation

KW - Patient Care Team

KW - Psychiatric Status Rating Scales

KW - Psychotropic Drugs

KW - Schizophrenia

KW - Schizophrenic Psychology

KW - Self Medication

KW - Street Drugs

KW - Substance-Related Disorders

M3 - SCORING: Zeitschriftenaufsatz

C2 - 9340658

VL - 24

SP - 185

EP - 189

JO - PSYCHIAT PRAX

JF - PSYCHIAT PRAX

SN - 0303-4259

IS - 4

ER -